Therefore, the present study puts forward that AC003991.1, EHMT2-AS1, LINC01018, TRIM52-AS1, AC093642.1, and AL445524.1 have pivotal roles in the onset or progress of HBV-related HCC by modulating the p53 signaling cascade. This evidence concerns the gene EHMT2 and hepatocellular carcinoma.